Unión Europea - español - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - inmunosupresores - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) está indicado para el tratamiento de pacientes adultos no tratados previamente con mieloma múltiple que no son elegibles para el trasplante. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 y 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) está indicado para el tratamiento de pacientes adultos no tratados previamente con mieloma múltiple que no son elegibles para el trasplante. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 y 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glenmark arzneimittel gmbh - lenalidomida - cÁpsula dura - 10 mg - lenalidomida 10 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glenmark arzneimittel gmbh - lenalidomida - cÁpsula dura - 15 mg - lenalidomida 15 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glenmark arzneimittel gmbh - lenalidomida - cÁpsula dura - 20 mg - lenalidomida 20 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glenmark arzneimittel gmbh - lenalidomida - cÁpsula dura - 25 mg - lenalidomida 25 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glenmark arzneimittel gmbh - lenalidomida - cÁpsula dura - 5 mg - lenalidomida 5 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

piramal critical care b.v. - lenalidomida - cÁpsula dura - 10 mg - lenalidomida 10 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

piramal critical care b.v. - lenalidomida - cÁpsula dura - 15 mg - lenalidomida 15 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

piramal critical care b.v. - lenalidomida - cÁpsula dura - 2,5 mg - lenalidomida 2,5 mg - lenalidomida

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

piramal critical care b.v. - lenalidomida - cÁpsula dura - 20 mg - lenalidomida 20 mg - lenalidomida